ELEVAI LABS INC.

Highlights Elevai Labs Inc.

Equities

ELAB

US28622K1043

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-20 pm EDT			5-day change	1st Jan Change
0.675 ^USD	-1.47%		+3.80%	-63.08%

May. 19	Certain Common Stock of Elevai Labs, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024.	CI
May. 02	Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity	May. 02	CI
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries	May. 01	CI
Elevai Labs Enters into Exclusive Licensing Agreement with MOA Life Plus Co., Ltd to Develop and Commercialize Two Novel Assets for the Treatment of Obesity and Muscle Loss Prevention	May. 01	CI
Elevai Labs Signs Exclusive Distribution Deal for Taiwan	Apr. 22	MT
Elevai Labs, Inc. Enters the Taiwan Market with Signing of 5Th International Distribution Agreement in 14 Months	Apr. 22	CI
Elevai Labs, Inc. Launches E-Commerce Portal	Mar. 18	CI
Elevai Labs, Inc. signed a license agreement to acquire a Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology from INmune Bio, Inc..	Jan. 15	CI
Elevai Labs, Inc. Announces New Partnership with Skin Sana Ltd	Dec. 07	CI
Elevai Labs, Inc. Enters into Licensing Agreement with Yuva Biosciences, Inc. to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products	Nov. 29	CI
Elevai Labs Closes IPO, Raises $6 Million	Nov. 24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW